Vitamin D Supplementation Associated to Better Survival in Hospitalized Frail Elderly COVID-19 Patients: The GERIA-COVID Quasi-Experimental StudyArticle Published on 2020-11-022022-10-30 Journal: Nutrients [Category] COVID-19, SARS, [키워드] acute phase Admission age baseline Better Cancer Cardiomyopathy Clinical improvement Comparator group confounder Corticosteroids COVID-19 COVID-19 diagnosis COVID-19 patients determine diagnosis of COVID-19 effective elderly functional Gender group hazard ratio Health hemoglobin highest hospital Hospitalized hypertension involved less lower risk Mortality no difference Odds ratio Older adults participant Patient pharmacological treatment Potential proportion Quasi-experimental study Regular respiratory disorders SARS-CoV-2 severe COVID-19 survival survived survivor Therapeutics three group Treatment use of antibiotics Vitamin D vitamin D supplement Vitamin D supplementation while women [DOI] 10.3390/nu12113377 PMC 바로가기 [Article Type] Article
Response to: Broadbent 2020, Better the drug you know: Commentary on “Daughton 2020, Natural experiment concept to accelerate the re-purposing of existing therapeutics for Covid-19”Short communication Published on 2020-11-012022-10-05 Journal: Global Epidemiology [Category] 신약개발, [키워드] accelerate Better natural experiment response [DOI] 10.1016/j.gloepi.2020.100028 [Article Type] Short communication
Better the drug you know: Commentary on “Daughton 2020, Natural experiment concept to accelerate the re-purposing of existing therapeutics for Covid-19”Short communication Published on 2020-11-012022-10-05 Journal: Global Epidemiology [Category] 신약개발, [키워드] accelerate Better natural experiment [DOI] 10.1016/j.gloepi.2020.100027 [Article Type] Short communication
COVID-19 and Systemic Lupus Erythematosus: Focus on Immune Response and TherapeuticsCOVID-19 및 전신성 홍반성 루푸스: 면역 반응 및 치료에 초점Review Published on 2020-10-302022-09-11 Journal: Frontiers in Immunology [Category] MERS, SARS, 유전자 메커니즘, [키워드] aberrant immune response affected Anti-viral Antiviral autoantibodies Autoimmune disease Better cause caused characterized circulating Clinical outcome clinical outcomes Comorbidities Coronavirus infection Coronaviruses COVID-19 COVID-19 pandemic cytokine Cytokine storm Cytokines damage death Defense Disease progression Ethnicity focus immune response Immune-mediated in viral individual Infection Infectious disease lead lung Lungs Lupus lupus erythematosus lymphopenia management mechanisms morbidity and mortality Novel coronavirus other organs Patient patients Population populations progression Proinflammatory cytokine proinflammatory cytokines PROTECT Regulatory response SARS-CoV-2 severity susceptible systemic systemic lupus erythematosus T cells the disease Therapeutic strategies therapeutic strategy Therapeutics tissues treated underlying condition underlying conditions vice Viral viral infections while [DOI] 10.3389/fimmu.2020.589474 PMC 바로가기 [Article Type] Review
May Mangafodipir or Other SOD Mimetics Contribute to Better Care in COVID-19 Patients?Viewpoint Published on 2020-10-102022-10-28 Journal: The Cochrane database of systematic reviews [Category] COVID-19, [키워드] accompanied acute respiratory syndrome administration Affect aggregation appear approach Better Cardiopulmonary characterized chronic obstructive clinical settings clinical trial Compound Concentration contrast agent coronavirus COVID-19 COVID-19 patient disease dismutase double-blind Efficacy Endothelium enzyme expected form GC4419 inactivation Inc Inflammation Inflammatory Inflammatory response inhibit kill life-threatening low molecular weight lung epithelial cell magnetic resonance imaging mangafodipir manganese manuscript MnSOD MnSOD-mimetic MRI Neutralizing Nitrate nitric oxide organ organs Other Patient patients pharmaceutical pharmacological Platelet PROTECT pulmonary disease Randomized resulting risk SARS-CoV-2 SARS-CoV-2 patient SARS-CoV-2 patients shown submission Superoxide sustained thrombosis Treatment vasoconstriction widespread [DOI] 10.3390/antiox9100971 PMC 바로가기 [Article Type] Viewpoint
A population-based cohort study of socio-demographic risk factors for COVID-19 deaths in SwedenArticle Published on 2020-10-092022-10-29 Journal: Nature Communications [Category] COVID-19, MERS, SARS, [키워드] agency Analysis being Better cause country COVID-19 death group higher risk highest Infectious diseases Interaction less male Mortality population-based cohort predict public health recorded risk factor Risk factors risk of death social environment Social sciences socio-demographic Sociology survival total population virus [DOI] 10.1038/s41467-020-18926-3 PMC 바로가기 [Article Type] Article
What every researcher should know about searching – clarified concepts, search advice, and an agenda to improve finding in academiaCommentary Published on 2020-10-082022-10-29 Journal: Research synthesis methods [Category] Coronavirus, MERS, SARS, [키워드] Better conducted COVID‐19 engage example explain exploratory Frame Google Scholar IMPROVE information initial pandemic Research researcher respond [DOI] 10.1002/jrsm.1457 PMC 바로가기 [Article Type] Commentary
Personal protective equipment for surgeons during COVID-19 pandemic: systematic review of availability, usage and rationingSystematic Review Published on 2020-09-242022-10-28 Journal: The British journal of surgery [Category] COVID-19, [키워드] analysed approach article associations Better college COVID-19 COVID-19 pandemic effective effort equipment Evidence Guidance inclusion criteria newspaper overcome Patient patient safety Personal protective equipment PPE Protective provide Public Health England resource Result Safe surgeon systematic review the WHO WHO [DOI] 10.1002/bjs.11750 PMC 바로가기 [Article Type] Systematic Review
End-Stage Renal Disease Patients on Chronic Hemodialysis Fare Better With COVID-19: A Retrospective Cohort Study From the New York Metropolitan RegionInfectious Disease Published on 2020-09-112022-10-31 Journal: Cureus [Category] COVID-19, [키워드] absolute mortality acute respiratory distress syndrome [ards] African American age analyzed Better better outcomes case sery Caucasians chronic Combined Community confidence interval Coronavirus disease 2019 (COVID-19) Course COVID-19 COVID-19 illness COVID-19 infection COVID-19 pneumonia defined dialysis distress end stage renal disease (esrd) End-stage renal disease ESRD Fare Hemodialysis higher odd hospital Hospitalized In-hospital likelihood Maintenance hemodialysis New York New York City outcome oxygen supplementation oxygen support pathophysiologic Patient patient cohort Primary outcome racial disparity Region Result retrospective risk factor secondary severe pneumonia syndrome World Health Organization [DOI] 10.7759/cureus.10373 PMC 바로가기 [Article Type] Infectious Disease
Survival and predictors of deaths of patients hospitalised due to COVID-19 from a retrospective and multicentre cohort study in BrazilOriginal Paper Published on 2020-09-072022-11-01 Journal: Epidemiology and Infection [Category] COVID-19, SARS, [키워드] age Asthma asthmatic Better Brazil calculated clinical factor cohort study Coronavirus infections COVID-19 death diabete diabetes disease distress Dyspnoea function hazard ratio hospital hospitalisation hospitalisations hospitalised HRs ICU increased risk intensive care invasive Kaplan–Meier Kidney disease log-rank test multicentre Multiple regression Neurological disease outbreak Patient pneumopathy predictor Prognosis Prognostic factors retrospective Risk factors SARS virus socio-demographic survival survival analysis survival curve survival function syndrome ventilatory support was used X-ray [DOI] 10.1017/S0950268820002034 PMC 바로가기 [Article Type] Original Paper